FDA approves new children’s vaccine from GlaxoSmithKline PLC

  Today, the FDA approved a new children's vaccine that targets two causes of bacterial meningitis, meningococcal disease and Hib disease.  The vaccine, MenHibrix, had been rejected twice before by the FDA, but GlaxoSmithKline said "it had resolved regulators’ questions about the vaccine’s potency and efficacy" according to Reuters.   The stats: 4,100 cases of bacterial meningitis occurred in the …